Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Botulinum Toxin A on Selective Motor Control in Cerebral Palsy: A Simultaneous Assessment of Upper and Lower Extremities

NCT06583343 is registered in ClinicalTrials.gov with Gaziosmanpasa Research and Education Hospital as lead sponsor.

NCT NCT06583343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06583343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Botulinum Toxin A on Selective Motor Control in Cerebral Palsy: A Simultaneous Assessment of Upper and Lower Extremities
Lead sponsor
Gaziosmanpasa Research and Education Hospital
Phase
Phase 4
Overall status
Completed
Start date
August 25, 2022
Completion date
April 25, 2024
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy spastic diplegia